June 20, 2025

Get In Touch



Hypocalcemia Associated With Adverse Outcomes In Patients Hospitalized With COVID-19

Researchers have found in a new study that Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19.
The new study conducted by Alessandro Minasi and team found that serum calcium observed on admission was negatively associated with proinflammatory indicators of severe COVID-19 and can be used to better characterize risk stratification for poor in-hospital outcomes.
The findings of this study were published in Endocrine Journal.

Numerous biological activities are regulated by calcium ions, and they may potentially have an impact on viral replication. In patients with critical illnesses and infectious infections, including those with COVID-19, hypocalcemia has been often described. It is strongly correlated with mortality and a pro-inflammatory condition. The purpose of this study was to ascertain the prevalence of hypocalcemia upon admission in COVID-19 (Coronavirus disease 2019) hospitalized patients and to assess the relationship between hypocalcemia and COVID-19 in-hospital outcomes.
Review of 118 patients who were hospitalized for COVID-19 between March and May 2020. At admission, data on the patient's clinical features, inflammatory indicators, biochemical routine, and mineral metabolism parameters were gathered. Total serum calcium levels under 2.2 mmol/L were considered hypocalcemic. Tertiles of total serum calcium were used to stratify the population. The primary outcome was a composite of in-hospital mortality or ICU admission (ICU). In-hospital deaths, ICU admissions, and the requirement for non-invasive breathing were all considered secondary outcomes. Cox-regression analysis and logistic regression were used with survival curves to test associations.
The key findings of this study were:
1. Only 6.7% of patients had levels of 25-(OH)-vitamin D more than 30 ng/ml, resulting in a 76.6% incidence of hypocalcemia overall.
2. Total serum calcium was negatively correlated (p 0.05) with a number of inflammatory indicators and a worse COVID-19 hospital outcome.
3. When compared to other groups, those with lower tertiles of total calcium (2.02 mmol/L) had an increased risk of in-hospital mortality (HR 2.77; 1.28–6.03, p = 0.01).
Reference:
Minasi, A., Andreadi, A., Maiorino, A., Giudice, L., De Taddeo, S., D'Ippolito, I., de Guido, I., Laitano, R., Romano, M., Ruotolo, V., Magrini, A., Di Daniele, N., Rogliani, P., Bellia, A., & Lauro, D. (2022). Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19. Endocrine. https://doi.org/10.1007/s12020-022-03239-w

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!